Published in Diabetes on February 01, 2011
Smad signaling pathways regulate pancreatic endocrine development. Dev Biol (2013) 0.93
Ectopic expression of GIP in pancreatic β-cells maintains enhanced insulin secretion in mice with complete absence of proglucagon-derived peptides. Diabetes (2012) 0.85
G protein-coupled receptor signaling and sphingosine-1-phosphate play a phylogenetically conserved role in endocrine pancreas morphogenesis. Mol Cell Biol (2011) 0.83
Alternative form of glucose-dependent insulinotropic polypepide and its physiology. J Diabetes Investig (2016) 0.75
Association of genetic variants of the incretin-related genes with quantitative traits and occurrence of type 2 diabetes in Japanese. Mol Genet Metab Rep (2014) 0.75
A synopsis of factors regulating beta cell development and beta cell mass. Cell Mol Life Sci (2016) 0.75
Carbohydrate-induced secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1. J Diabetes Investig (2016) 0.75
Biology of incretins: GLP-1 and GIP. Gastroenterology (2007) 10.45
Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects. J Clin Invest (1967) 3.60
Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med (2002) 3.55
Fibronectin requirement in branching morphogenesis. Nature (2003) 3.41
Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology (1995) 3.17
Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides. Regul Pept (1999) 3.01
Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A (1999) 2.29
The incretin concept today. Diabetologia (1979) 2.18
Minireview: the glucagon-like peptides. Endocrinology (2001) 2.15
Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. Endocrinology (2006) 2.08
Lineage-specific morphogenesis in the developing pancreas: role of mesenchymal factors. Development (1996) 1.89
Entero-insular axis. Arch Intern Med (1969) 1.74
Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology (1993) 1.68
GIP biology and fat metabolism. Life Sci (2000) 1.44
Pax genes and the differentiation of hormone-producing endocrine cells in the pancreas. Mech Dev (2000) 1.34
Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice. Diabetes (1998) 1.28
Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion. Gastroenterology (2010) 1.20
Glucagon is required for early insulin-positive differentiation in the developing mouse pancreas. Diabetes (2002) 1.13
Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis. Am J Physiol Endocrinol Metab (2003) 1.09
Abrogation of protein convertase 2 activity results in delayed islet cell differentiation and maturation, increased alpha-cell proliferation, and islet neogenesis. Endocrinology (2003) 1.08
Overview of incretin hormones. Horm Metab Res (2005) 0.88
Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo. J Endocrinol (2002) 0.86
Co-localization of neuroendocrine hormones in the human fetal pancreas. Eur J Endocrinol (1999) 0.84
Endocrine-committed progenitor cells retain their differentiation potential in the absence of neurogenin-3 expression. Biochem Biophys Res Commun (2010) 0.83
Glucose-dependent insulinotropic peptide (GIP) gene expression in the rat salivary gland. Mol Cell Endocrinol (1995) 0.81
Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet (2010) 6.81
N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res (2004) 2.35
Necrotizing enterocolitis in full-term infants. J Pediatr Surg (2003) 1.85
Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol (2009) 1.83
Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2. Proc Natl Acad Sci U S A (2003) 1.79
CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther (2004) 1.74
Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway. Cancer Res (2007) 1.68
Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology (2012) 1.59
Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res (2006) 1.55
No evidence for β cell neogenesis in murine adult pancreas. J Clin Invest (2013) 1.54
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother (2007) 1.49
Ectopic pancreas formation in Hes1 -knockout mice reveals plasticity of endodermal progenitors of the gut, bile duct, and pancreas. J Clin Invest (2006) 1.48
Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide. Clin Cancer Res (2008) 1.41
Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun (2004) 1.36
The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy. Diabetes (2002) 1.35
Duct cells contribute to regeneration of endocrine and acinar cells following pancreatic damage in adult mice. Gastroenterology (2011) 1.35
M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci U S A (2014) 1.35
Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol (2007) 1.28
RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clin Cancer Res (2003) 1.25
Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium. Proc Natl Acad Sci U S A (2012) 1.24
TGFβ receptor signaling is essential for inflammation-induced but not β-cell workload-induced β-cell proliferation. Diabetes (2012) 1.21
In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer. Int J Cancer (2006) 1.20
Preclinical pharmacokinetic/pharmacodynamic models of gefitinib and the design of equivalent dosing regimens in EGFR wild-type and mutant tumor models. Mol Cancer Ther (2008) 1.20
Survivin expression is a prognostic marker in pancreatic cancer patients. Surgery (2004) 1.18
The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice. Cancer Res (2003) 1.18
Embryonic mouse blood flow and oxygen correlate with early pancreatic differentiation. Dev Biol (2010) 1.17
Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg (2009) 1.17
Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol (2010) 1.16
Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma. Int J Cancer (2003) 1.15
Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. Surgery (2003) 1.14
Glucagon is required for early insulin-positive differentiation in the developing mouse pancreas. Diabetes (2002) 1.13
Predicting human tumor drug concentrations from a preclinical pharmacokinetic model of temozolomide brain disposition. Clin Cancer Res (2007) 1.10
A smad signaling network regulates islet cell proliferation. Diabetes (2013) 1.08
TGF-beta isoform signaling regulates secondary transition and mesenchymal-induced endocrine development in the embryonic mouse pancreas. Dev Biol (2007) 1.06
Lectin as a marker for staining and purification of embryonic pancreatic epithelium. Biochem Biophys Res Commun (2002) 1.06
Downregulation of miR-223 and miR-153 mediates mechanical stretch-stimulated proliferation of venous smooth muscle cells via activation of the insulin-like growth factor-1 receptor. Arch Biochem Biophys (2012) 1.06
Hypoglycemia reduces vascular endothelial growth factor A production by pancreatic beta cells as a regulator of beta cell mass. J Biol Chem (2013) 1.06
Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis. Int J Oncol (2006) 1.05
Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage. Cancer Res (2007) 1.04
Cross-talk between bone morphogenetic protein and transforming growth factor-beta signaling is essential for exendin-4-induced insulin-positive differentiation of AR42J cells. J Biol Chem (2005) 1.04
Minimally invasive congenital diaphragmatic hernia repair: a 7-year review of one institution's experience. Surg Endosc (2008) 1.04
Pancreatic duct cells as a source of VEGF in mice. Diabetologia (2014) 1.03
Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. Surgery (2005) 1.02
The formation of daodi medicinal materials. J Ethnopharmacol (2012) 1.01
Pharmacodynamic-mediated effects of the angiogenesis inhibitor SU5416 on the tumor disposition of temozolomide in subcutaneous and intracerebral glioma xenograft models. J Pharmacol Exp Ther (2003) 1.01
Multifaceted pancreatic mesenchymal control of epithelial lineage selection. Dev Biol (2004) 1.00
An effective pyloromyotomy length in infants undergoing laparoscopic pyloromyotomy. Surgery (2004) 0.99
Clinical significance of focal adhesion kinase in resectable pancreatic cancer. World J Surg (2006) 0.99
Management of postoperative infections after the minimally invasive pectus excavatum repair. J Pediatr Surg (2005) 0.99
Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis. J Biol Chem (2014) 0.98
Rapid and simplified purification of recombinant adeno-associated virus. J Virol Methods (2012) 0.98
A new Tn1546 type of VanB phenotype-vanA genotype vancomycin-resistant Enterococcus faecium isolates in mainland China. Diagn Microbiol Infect Dis (2009) 0.97
Loss of function of the candidate tumor suppressor prox1 by RNA mutation in human cancer cells. Neoplasia (2006) 0.97
Pharmacokinetic model-predicted anticancer drug concentrations in human tumors. Clin Cancer Res (2004) 0.97
Sugar binding to recombinant wild-type and mutant glucokinase monitored by kinetic measurement and tryptophan fluorescence. Biochem J (2008) 0.97
Pancreatic epithelial cells can be converted into insulin-producing cells by GLP-1 in conjunction with virus-mediated gene transfer of pdx-1. Surgery (2005) 0.96
Effects of four Si-Wu-Tang's constituents and their combination on irradiated mice. Biol Pharm Bull (2006) 0.96
Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin. Cancer Res (2002) 0.96
Urachal anomalies in children: the vanishing relevance of the preoperative voiding cystourethrogram. J Pediatr Surg (2005) 0.95
All-trans retinoic acid induces differentiation of ducts and endocrine cells by mesenchymal/epithelial interactions in embryonic pancreas. Diabetes (2003) 0.95
Maternal microchimerism in biliary atresia. J Pediatr Surg (2007) 0.95
Neurogenin3 activation is not sufficient to direct duct-to-beta cell transdifferentiation in the adult pancreas. J Biol Chem (2013) 0.94